Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teads Holding (TEAD) Cash & Equivalents (2019 - 2025)

Teads Holding (TEAD) has disclosed Cash & Equivalents for 7 consecutive years, with $35.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 60.69% to $35.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.0 million through Dec 2025, down 60.69% year-over-year, with the annual reading at $35.0 million for FY2025, 60.69% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $35.0 million at Teads Holding, down from $130.8 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $482.4 million in Q3 2021, with the low at $32.9 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $154.3 million, with a median of $92.1 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents surged 475.34% in 2021, then plummeted 84.72% in 2023.
  • Over 5 years, Cash & Equivalents stood at $455.4 million in 2021, then plummeted by 76.82% to $105.6 million in 2022, then tumbled by 32.86% to $70.9 million in 2023, then rose by 25.68% to $89.1 million in 2024, then plummeted by 60.69% to $35.0 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $35.0 million, $130.8 million, and $32.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.